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Regulated expression of an immunoglobulin K gene introduced into
a mouse lymphoid cell line
(Abelson murine leukemia virus/DNA transfection/gpt selection/lipopolysaccharide induction)
DoUGLAs RICE AND DAVID BALTIMORE
The Whitehead Institute for Biomedical Research, the Center for Cancer Research, and the Department of Biology, Massachusetts Institute of Technology,
Cambridge, Massachusetts 02139
Contributed by David Baltimore, September 16, 1982
ABSTRACT We have introduced a functionally rearranged
murine c light chain immunoglobulin (Ig) gene into an Abelson
murine leukemia virus-transformed lymphoid cell line. Plasmid
pSV2gpt-ic41, containing the c light chain gene from the myeloma
MOPC41 and the selectable marker gene gpt, was introduced into
81A-2 cells by the calcium phosphate coprecipitation technique.
Cells expressing the gpt gene were selected by growth in medium
containing mycophenolic acid. One transfected cell line, K-2, was
shown to make K mRNA and polypeptide chains and to assemble
the K chain product with y2b heavy chains to form an apparently
complete IgG2b. When bacterial lipopolysaccharide was added to
the growth medium, levels ofK mRNA and polypeptide increased,
showing regulated expression of the introduced K gene.
B cell differentiation proceeds from the "pre-B" lymphocyte,
which synthesizes A immunoglobulin (Ig) heavy chains but no
light chains, to the mature B lymphocyte, which synthesizes
both heavy and light chains and expresses surface Ig, and finally
to the Ig-secreting plasma cell (1-5). The availability of trans-
formed cell analogs has allowed biochemical characterization of
these stages of cellular differentiation (6-11). Recently, such
studies have contributed greatly to our understanding of the
structure of Ig gene segments and the joining of these segments
to produce a functionally rearranged Ig gene (12-17).
Although much is now known about Ig gene structure, rel-
atively little is known about the molecular mechanisms that
control Ig gene expression. One approach to study such controls
is to introduce Ig genes into various cell lines, including both
lymphoid cells at various stages of differentiation and nonlym-
phoid cells. One might then be able to identify control mech-
anisms unique to lymphoid cells that allow the cells to express,
assemble, and secrete Igs. To begin such studies, we have at-
tempted to introduce a functionally rearranged murine K light
chain gene into an Abelson murine leukemia virus (A-MuLV)-
transformed lymphoid cell line.
Previous studies have shown that A-MuLV infection of bone
marrow or fetal liver cells transforms cells of the B-lymphoid
lineage, usually "pre-B" cells (18, 19). Derivatives of one A-
MuLV transformant, 18-8, have been shown to switch from a
to y2b heavy chain synthesis while in culture (20-22). One such
derivative, 81A-2, synthesizes y2b protein, but has lost its K
constant region light chain gene segments (unpublished data).
Here we report that, after the introduction of a functionally
rearranged K gene into 81A-2 cells, the K gene is expressed in
a regulated manner.
MATERIALS AND METHODS
Cells. The A-MuLV-transformed cell line 81A-2, a derivative
of the line 18-8, synthesizes y2b heavy chain protein, but no
light chain, and has lost its K constant region genes (refs. 18 and
22; unpublished data). Cells were grown and analyzed for Ig
protein synthesis by metabolic labeling and immunoprecipita-
tion as described (18). Nonreduced samples were prepared for
electrophoresis as described by Margulies et al. (23).
DNA Procedures. The phage ACh4A-41KC21, containing
the rearranged genomic K light chain gene from the myeloma
MOPC41, was obtained from P. Leder (12). The 7-kilobase-pair
(kbp) EcoRI/BamHI fragment containing the K gene was in-
serted into EcoRI- and BamHI-cleaved plasmid pSV2gpt, ob-
tained from R. Mulligan (24). The resulting plasmid, shown in
Fig. 1, is called pSV2gpt-K41. Ten micrograms of DNA from
this plasmid was transfected into 5 x 107 81A-2 cells by a mod-
ification ofthe calcium phosphate technique ofGraham and Van
der Eb (25). Cells were washed in phosphate-buffered saline
(0.14 M NaCl/2.5 mM KCl/16 mM Na2HPO4/1.4 mM
KH2PO4), resuspended in 1 ml of transfection cocktail [made
by adding DNA to 1 ml of Hepes-buffered saline, then adding
62.5 j1. of 2 M CaCl2 (26)] and incubated 15 min at room tem-
perature. Then 10 ml of medium was added and the cells were
incubated at 370C for 4 hr. Cells were then washed in phos-
phate-buffered saline, incubated at 37°C for 2 min in 2 ml of
Hepes-buffered saline with glycerol (26), and washed again in
phosphate-buffered saline. Cells were then resuspended in 10
ml of nonselective medium, grown for 3 days, and then trans-
ferred to selective medium [RPMI 1640 medium supplemented
with mycophenolic acid at 2 ug/ml, xanthine at 250 ug/ml,
hypoxanthine at 15 ,g/ml, and glutamine at 150 ,ug/ml (27)].
Transfected and mock-transfected 81A-2 cells were passaged in
selective medium for approximately 3 weeks, until the mock-
transfected cells had died. The transfected cells were then
cloned by limiting dilution in nonselective medium.
RNA. Total cellular poly(A)-containing RNA was isolated by
the guanidine-HCl procedure (28), fractionated according to
size by electrophoresis in formaldehyde gels (29), transferred
to nitrocellulose, and hybridized with 32P-labeled DNA probes
as described (30).
RESULTS
To examine expression of a K gene from transfected plasmid
DNA, the plasmid pSV2gpt-K41 was constructed to contain the
rearranged chromosomal K light chain gene from the myeloma
MOPC41 (12) and the selectable marker gene gpt, the gene
from Escherichia coli that codes for the enzyme xanthine-gua-
nine phosphoribosyltransferase [GPT; EC 2.4.2.22 (27)] (Fig.
1). In mammalian cells grown in media containing inhibitors of
purine synthesis (here, mycophenolic acid), expression of the
gpt gene allows selective cell growth using xanthine as the pre-
Abbreviations: A-MuLV, Abelson murine leukemia virus; GPT, xan-
thine-guanine phosphoribosyltransferase; kb, kilobase(s); kbp, kilobase
pair(s); LPS, bacterial lipopolysaccharide; SV40, simian virus 40.
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FIG. 1. Structure of the plasmid pSV2gpt-K41 (11.4 kbp). Mouse
DNA sequences containing the rearranged K light chain gene from the
myeloma MOPC41 are represented by the heavy dark line. The leader
(L), variable plus joining region (VJ), and constant region (CK) of the
K gene are indicated. Simian virus 40 (SV40) sequences, represented
by hatched regions, include DNA segments containing the early pro-
moter, the small tumor antigen intervening sequence, and sequences
for termination and polyadenylylation of SV40 early transcripts. The
gpt gene fromEscherichia coli is shown as a stippled region. ori, Origin
of replication; ampr, ampicillin resistance. Transcription units are in-
dicated by wavy lines.
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cursor for synthesis ofguanine nucleotides (27). In pSV2gpt, the
parental plasmid used for this construction, the gpt gene is tran-
scribed from the SV40 early promoter and is followed by a re-
gion of SV40 DNA containing the small tumor antigen inter-
vening sequence and signal sequences for transcript termination
and polyadenylylation (24). To reduce the possibility of tran-
scription of the K light chain gene from promoters other than
its own, plasmid pSV2gpt-K41 was designed so that transcrip-
tion from the SV40 promoter is in opposite orientation from that
required for K gene expression.
The 81A-2 cell line used as recipient of the transfected DNA
is an A-MuLV-transformed murine lymphoid cell that synthe-
sizes y2b heavy chain but no light chain [no CK alleles can be
detected by hybridization (ref. 22 and unpublished data)]. Plas-
mid pSV2gpt-K41 DNA was introduced into 81A-2 cells by the
calcium phosphate coprecipitation technique (25). Cells ex-
pressing the gpt gene were selected by growth in medium con-
taining mycophenolic acid and then cloned by limiting dilution.
When DNA from three selected cell lines was prepared and
analyzed by hybridization with a K probe, all three lines were
found to have acquired one or a small number ofthe introduced
K genes. From the pattern ofthe hybridizing bands, at least two
of three lines were judged to be independent transfectants.
Eight cell lines were assayed for GPT enzyme activity by the
in situ gel assay ofMulligan and Berg (24); all eight were positive
(data not shown).
When the eight gpt+ cell lines were assayed for production
of K protein by metabolic labeling with [3S]methionine and im-
munoprecipitation with anti-K antiserum, all eight were found
to synthesize a polypeptide which (i) was precipitable with anti-
K antiserum (Fig. 2, lane d for clone K-2 and data not shown for
the others); (ii) comigrated with the K chain produced by the
myeloma MPC1l (apparent Mr 23,000) (Fig. 2, lane a); and (iii)
was not evident in the nontransfected 81A-2 parent cell line
(Fig. 2, lane b). In the original autoradiogram, the background
bands in the Mr 23,000 region are much fainter than reproduced
here. Because the 81A-2 cells lack CK alleles, none of the back-
ground bands are K light chain. Precipitation of the Mr 23,000
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FIG. 2. Polyacrylamide gel electrophoresis of Ig polypeptides syn-
thesized by 81A-2 cells and the transfectant K-2. Cytoplasmic extracts
were prepared from cells labeled with [35S]methionine, immunopre-
cipitated, and analyzed by NaDodSO4/polyacrylamide gel electropho-
resis. Lane a, myeloma MPC11 extract immunoprecipitated with anti-
K antiserum; lanes b and c, extract from parent A-MuLV-transformant
81A-2 grown in the absence (lane b) and presence (lane c) of Salmonella
typhimurium lipopolysaccharide (LPS) and immunoprecipitated with
anti-K antiserum; lanes d and e, extract from the transfectant K-2
grown in the absence (lane d) and presence (lane e) of LPS and im-
munoprecipitated with anti-K antiserum; lanes f and g, extract from
the transfectant K-2 mixed with unlabeled MPC11 extract (lane f) or
unlabeled MOPC104E extract (lane g) and immunoprecipitated with
anti-K antiserum; lane h, extract from the transfectant K-2 immuno-
precipitated with anti-AT antiserum. Sizes of molecular weight marker
proteins are indicated.
polypeptide by anti-K serum was blocked by competition with
an unlabeled MPC11 protein extract (containing authentic K
light chains) but not by an unlabeled MOPC104E protein ex-
tract (containing AI light chains) (Fig. 2, lanes fand g). Also, the
apparent K chain was not precipitable by anti-AI antiserum (Fig.
2, lane h). Therefore, the Mr 23,000 polypeptide appears to be
the protein product of the K light chain gene transfected into
the 81A-2 cells.
To examine the RNA produced from the transfected K gene,
poly(A)-containing mRNA was prepared from the parent 81A-
2 cell line and the transfectant K-2. The RNA was size-fraction-
ated by agarose gel electrophoresis, transferred to nitrocellu-
lose, and hybridized with a 32P-labeled plasmid DNA probe
containing the K constant region (CK), the K joining (J,) seg-
ments, and the sequence that intervenes between them. No
hybridization was detected to the RNA prepared from the par-
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FIG. 3. Analysis of K RNA transcripts in the transfectant K-2.
Poly(A)-containing RNA was isolated from cells, size-fractionated by
agarose gel electrophoresis, transferred to nitrocellulose paper, and
hybridized with 32P-labeled DNA from a plasmid containing the se-
quence from J. through CK. Lanes a and b, RNA from the transfectant
K-2 grown in the absence (lane a) or presence (lane b) of LPS. Lane c,
RNA from the K-producing A-MuLV-transformed cell line 18-48.
ent line 81A-2 (not shown), but RNA from the K-2 line contained
hybridizing species ofapproximately 1.2, 1.9, and 2.6 kilobases
(kb) (Fig. 3, lane a). The smaller RNA comigrated with authentic
K mRNA from the A-MuLV-transformed cell line 18-48 (Fig.
3, lane c). [The smaller 0.8-kb RNA in 18-48 is an aberrantly
small K transcript (5).] In other experiments, both the 1.9-kb
and the 2.6-kb RNAs were found to hybridize strongly to a probe
specific for the intervening sequence between JK and CK and
hybridize weakly to a pBR322 DNA probe. Hence, these higher
molecular weight species are some type of aberrant RNA. The
1.2-kb species, however, appears to be an authentic K mRNA
transcript in that it hybridizes only to the probe containing K
coding sequences and not to the intervening sequence probe
or pBR322.
Because many A-MuLV-transformed lymphoid cell lines in-
crease Ig production when LPS is added to the medium (18, 31),
we investigated the effects of LPS on K chain synthesis in the
transfected line. The parent line 81A-2 increases synthesis of
y2b heavy chain protein and mRNA upon induction by LPS
(22) (Fig. 2, lane c). When LPS was added to the K-2 cells, K
light chain synthesis increased approximately 5-fold, to a level
approximately 1/15th that of the myeloma MPC1l (Fig. 2, lane
e). To determine if the LPS-induced increase in K chain syn-
thesis was due to an increased content of specific mRNA, the
mRNA fraction was prepared from LPS-treated 81A-2 parent
cells and transfected K-2 cells. Again, no K mRNA species was
FIG. 4. Polyacrylamide gel electrophoresis of nonreduced Ig syn-
thesized by the K-2 transfectant. Cytoplasmic extracts were prepared
as for Fig. 2. Lanes a and b, extracts from the parent 81A-2 cells grown
without (lane a) and with (lane b) LPS and immunoprecipitated with
anti-K antiserum; lanes c and d, extract from K-2 transfectants grown
without (lane c) and with (lane d) LPS and immunoprecipitated with
anti-K antiserum; lane e, myeloma MPC11 extract immunoprecipi-
tated with anti-K antiserum.
detected in the parental cells, but the K-2 cells contained in-
creased levels of the 1.2- and 1.9-kb species (Fig. 3, lane b).
Interestingly, the level of the 1.9-kb RNA species increased
even more than that of the presumably authentic 1.2-kb RNA
species.
Because the transfected cells were producing both y2b heavy
chains and K light chains, it was possible that the cells could
assemble the heavy and light chains into IgG. To examine this
question, samples of [35S]methionine-labeled protein extracts
were immunoprecipitated with anti-K antiserum and the non-
reduced samples were subjected to NaDodSO4/polyacryl-
amide gel electrophoresis. The parental 81A-2 cells produced
a protein of approximately the correct size for y2b heavy chain
dimers (Fig. 4, lanes a and b; the darker appearance of lane a
is due to more labeled extract present). The K-2 cells produced
a protein that migrated slightly faster than the IgG2b produced
by the myeloma MPC11 (Fig. 4, lanes d and e) but slower than
the bulk of the rabbit IgG antiserum visualized by staining (not
shown). In other experiments (not shown) no free K chain was
found in the K-2 cells, although a significant amount was present
in MPC1L cells. Essentially all of the K chain produced in the
K-2 cells appears to be assembled into IgG2b.
DISCUSSION
The major result of these studies is the demonstration that a
functional K gene can be introduced into a lymphoid cell line
in which it will be continuously expressed. This opens the pos-
sibility of examining control and rearrangement mechanisms in
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lymphoid cells by using inserted genetic elements.
The K gene introduced into 81A-2 cells apparently functions
normally in spite of being in a very unusual context. The gene
was in an SV40/pBR322 vector that then integrated into a pre-
sumably random site in the cell genome, a site unlikely to be
related to the normal location of the K gene in chromosome 6.
In spite of its unusual context, the introduced gene was ex-
pressed at about the same level as the resident y2b heavy chain
gene. The K gene was apparently using its own promoter be-
cause in the construction no promoter was provided that faced
-in the correct direction. It is possible that the SV40 DNA se-
quences present might have provided some enhancing function
for K expression (32).
The introduced K gene not only was expressed at a basal level
but also- was inducible by LPS. The mechanism and function
of this induction system are far from clear, but the ability of the
introduced K gene to respond indicates that sufficient K-related
DNA sequences to provide for LPS inducibility were included
in the construct. The construct contained, in addition to the VK,
JK1 and CK coding segments, the intervening sequence between
the coding regions and about 1-L5 kb of DNA both 5' of VKJK
and 3' of CK. Any of this extra DNA could be involved in pro-
moter and control functions, but the results make it unlikely that
any sequences important for K expression exist more than 1.5
kb to either side of the coding region.
LPS control of heavy chain expression in 81A-2 cells is allele
specific and correlates with a deletion in the intervening se-
quence between VHDJH and CM (22, 33). The productively rear-
ranged heavy chain allele is inducible by LPS and contains this
deletion, whereas the other allele, containing a nonproductive
rearrangement, lacks the deletion and is not inducible by LPS.
Therefore, LPS inducibility of heavy chain seems to be deter-
mined at the DNA level. Whether the introduced K gene is
responding directly to LPS or to the product of the heavy chain
allele is an open question. The possibility that transcription of
the light chain gene is controlled by a product ofthe heavy chain
locus is an interesting possibility and needs further investigation.
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